PL2842563T3 - Kompozycja zawierająca sproszkowaną błonę skorupki jaj do stosowania w leczeniu ssaków w stanie przedcukrzycowym - Google Patents

Kompozycja zawierająca sproszkowaną błonę skorupki jaj do stosowania w leczeniu ssaków w stanie przedcukrzycowym

Info

Publication number
PL2842563T3
PL2842563T3 PL14182072.0T PL14182072T PL2842563T3 PL 2842563 T3 PL2842563 T3 PL 2842563T3 PL 14182072 T PL14182072 T PL 14182072T PL 2842563 T3 PL2842563 T3 PL 2842563T3
Authority
PL
Poland
Prior art keywords
treating
composition
eggshell membrane
diabetic mammals
powdered eggshell
Prior art date
Application number
PL14182072.0T
Other languages
English (en)
Inventor
Kevin Ruff
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL2842563T3 publication Critical patent/PL2842563T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/57Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL14182072.0T 2010-04-12 2011-04-12 Kompozycja zawierająca sproszkowaną błonę skorupki jaj do stosowania w leczeniu ssaków w stanie przedcukrzycowym PL2842563T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32330310P 2010-04-12 2010-04-12

Publications (1)

Publication Number Publication Date
PL2842563T3 true PL2842563T3 (pl) 2016-12-30

Family

ID=44798988

Family Applications (2)

Application Number Title Priority Date Filing Date
PL14182072.0T PL2842563T3 (pl) 2010-04-12 2011-04-12 Kompozycja zawierająca sproszkowaną błonę skorupki jaj do stosowania w leczeniu ssaków w stanie przedcukrzycowym
PL11769433T PL2557920T3 (pl) 2010-04-12 2011-04-12 Kompozycja zawierająca sproszkowaną błonę skorupy jajka przeznaczona do wykorzystania w terapii cukrzycy

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL11769433T PL2557920T3 (pl) 2010-04-12 2011-04-12 Kompozycja zawierająca sproszkowaną błonę skorupy jajka przeznaczona do wykorzystania w terapii cukrzycy

Country Status (13)

Country Link
US (2) US8679551B2 (pl)
EP (2) EP2557920B1 (pl)
CN (2) CN105250335B (pl)
AU (1) AU2011240764B2 (pl)
CA (1) CA2796336C (pl)
CY (2) CY1116808T1 (pl)
ES (2) ES2528413T3 (pl)
MX (1) MX2012011881A (pl)
NZ (1) NZ602949A (pl)
PL (2) PL2842563T3 (pl)
PT (2) PT2557920E (pl)
RS (2) RS55025B1 (pl)
WO (1) WO2011130261A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2440390B1 (es) * 2012-07-25 2014-11-13 Bioibérica, S.A. Composiciones para el tratamiento del sobrepeso y de la obesidad
JP5998350B2 (ja) * 2013-03-27 2016-09-28 国立大学法人 東京大学 卵殻膜成分を含む肝保護剤ならびにそれを用いた医薬組成物、食品添加物および食品
JP2014231487A (ja) * 2013-05-28 2014-12-11 国立大学法人 東京大学 卵殻膜成分を含むサーチュイン遺伝子活性化剤ならびにそれを用いた組成物
US20140363519A1 (en) * 2013-06-11 2014-12-11 The University Of Tokyo Activator of gene expression of molecular chaperone gene comprising eggshell membrane component and composition thereof
EP3643320A1 (en) * 2013-07-08 2020-04-29 International Dehydrated Foods, Inc. Compositions prepared from poultry and methods of their use
US11478504B2 (en) 2013-07-08 2022-10-25 International Dehydrated Foods, Inc. Compositions and methods for preventing/treating metabolic syndrome
JP6056064B2 (ja) * 2013-11-29 2017-01-11 国立大学法人 東京大学 卵殻膜成分を含むインスリン抵抗性改善剤ならびにそれを用いた組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652221A (en) * 1994-11-07 1997-07-29 The University Of Virginia Patent Foundation Method of treating defective glucose metabolism using synthetic insulin substances
GB0213612D0 (en) * 2002-06-13 2002-07-24 Novartis Nutrition Ag Organic compounds
DE20213669U1 (de) * 2002-09-02 2004-02-12 Ewald Speth Antriebstechnik Gmbh Direkt angetriebene Antriebsachse mit einer an axial festgelegtes Sonnenritzel aufweisenden Getriebestufe
US20080063677A1 (en) * 2004-03-10 2008-03-13 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
KR100662903B1 (ko) * 2004-12-14 2007-01-02 건국대학교 산학협력단 글루코사민 하이드로클로라이드를 함유하는 당뇨 질환치료용 의약 조성물
CA2556343A1 (en) * 2005-09-01 2007-03-01 Purepharm Inc. Synthetic nutritional formulations
CN102325535A (zh) * 2009-02-23 2012-01-18 帝斯曼知识产权资产管理有限公司 用于炎性病症的cajanus提取物和葡糖胺

Also Published As

Publication number Publication date
AU2011240764B2 (en) 2014-07-10
AU2011240764A1 (en) 2012-11-08
EP2842563B1 (en) 2016-05-25
EP2557920B1 (en) 2014-11-12
WO2011130261A1 (en) 2011-10-20
CA2796336C (en) 2018-06-05
US20130089619A1 (en) 2013-04-11
PL2557920T3 (pl) 2015-04-30
ES2528413T3 (es) 2015-02-10
RS55025B1 (sr) 2016-11-30
US8927032B2 (en) 2015-01-06
RS53826B1 (en) 2015-06-30
CN105250335A (zh) 2016-01-20
EP2557920A4 (en) 2013-10-23
PT2557920E (pt) 2015-02-05
US8679551B2 (en) 2014-03-25
CN103002736B (zh) 2015-11-25
PT2842563T (pt) 2016-07-14
CN103002736A (zh) 2013-03-27
EP2557920A1 (en) 2013-02-20
US20140193516A1 (en) 2014-07-10
MX2012011881A (es) 2013-04-19
CN105250335B (zh) 2019-10-29
CY1116808T1 (el) 2017-03-15
ES2579340T3 (es) 2016-08-10
NZ602949A (en) 2014-11-28
CA2796336A1 (en) 2011-10-20
EP2842563A1 (en) 2015-03-04
CY1117799T1 (el) 2017-05-17

Similar Documents

Publication Publication Date Title
EP2644185A4 (en) THICK CLEANING COMPOSITION
GB201002983D0 (en) Nutritinal composition
GB201006699D0 (en) Composition
GB201021186D0 (en) Composition
ZA201302113B (en) Caspofungin composition
PT2842563T (pt) Composição compreendendo uma membrana de casca de ovo em pó para utilização no tratamento de diabetes mellitus
GB201006178D0 (en) Composition
GB201010374D0 (en) Disinfectant composition
HK1185815A1 (zh) 牙科組合物
GB201017048D0 (en) Composition
EP2534302A4 (en) SURFACE TREATMENT COMPOSITION
GB201019988D0 (en) Composition
GB201016970D0 (en) Composition
GB201006214D0 (en) Composition
GB201018083D0 (en) Absorbant Composition
GB201006204D0 (en) Composition
GB201004717D0 (en) Composition
GB201014967D0 (en) Composition
GB201010657D0 (en) Composition
GB201006175D0 (en) Composition
GB201018130D0 (en) Composition
GB201006182D0 (en) Composition
GB201006012D0 (en) Composition
GB201002356D0 (en) Composition
PL390851A1 (pl) Blat stołu